Opinion Article
Position Statement of the Spanish Academy of Dermatology and Venereology on Teledermatology
Posicionamiento de la Academia Española de Dermatología y Venereología sobre la teledermatología
D. Moreno-Ramíreza,
, G. Romero-Aguilerab, P. Pasqualic, S. Vañod, L. Ríos-Bucetad,e, J. Malvehyf, R. Tabernerg, L. Ferrándiza, e-Dermatology and Imaging Group of the Spanish Academy of Dermatology and Venereology
Corresponding author
a Unidad de Gestión Clínica de Dermatología, Hospital Universitario Virgen Macarena, Sevilla, Spain
b Servicio de Dermatología, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain
c Servicio de Dermatología, Hospital Pius de Valls, Valls, Tarragona, Spain
d Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, Spain
e Junta Directiva, Academia Española de Dermatología y Venereología, Madrid, Spain
f Servicio de Dermatología, Hospital Clínic, Barcelona, Spain
g Servicio de Dermatología Hospital Son Llàzter, Palma de Mallorca, Spain
Read
5049
Timeswas read the article
2060
Total PDF
2989
Total HTML
Share statistics
array:24 [ "pii" => "S1578219017303815" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.09.002" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1803" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2017" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:4-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 317 "formatos" => array:3 [ "EPUB" => 18 "HTML" => 224 "PDF" => 75 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731017305173" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.09.004" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1803" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:4-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1046 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 861 "PDF" => 183 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">ARTÍCULO DE OPINIÓN</span>" "titulo" => "Posicionamiento de la Academia Española de Dermatología y Venereología sobre la teledermatología" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "4" "paginaFinal" => "5" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Position Statement of the Spanish Academy of Dermatology and Venereology on Teledermatology" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "D. Moreno-Ramírez, G. Romero-Aguilera, P. Pasquali, S. Vaño, L. Ríos-Buceta, J. Malvehy, R. Taberner, L. Ferrándiz" "autores" => array:9 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Moreno-Ramírez" ] 1 => array:2 [ "nombre" => "G." "apellidos" => "Romero-Aguilera" ] 2 => array:2 [ "nombre" => "P." "apellidos" => "Pasquali" ] 3 => array:2 [ "nombre" => "S." "apellidos" => "Vaño" ] 4 => array:2 [ "nombre" => "L." "apellidos" => "Ríos-Buceta" ] 5 => array:2 [ "nombre" => "J." "apellidos" => "Malvehy" ] 6 => array:2 [ "nombre" => "R." "apellidos" => "Taberner" ] 7 => array:2 [ "nombre" => "L." "apellidos" => "Ferrándiz" ] 8 => array:1 [ "colaborador" => "Grupo de e-Dermatología e Imagen de la Academia Española de Dermatología y Venereología" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219017303815" "doi" => "10.1016/j.adengl.2017.09.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303815?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017305173?idApp=UINPBA000044" "url" => "/00017310/0000010900000001/v1_201801020548/S0001731017305173/v1_201801020548/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219017303591" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.11.003" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1675" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2018;109:6-23" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 504 "formatos" => array:3 [ "EPUB" => 17 "HTML" => 402 "PDF" => 85 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Treatment of Malignant Cutaneous Adnexal Neoplasms" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "6" "paginaFinal" => "23" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento de las neoplasias anexiales cutáneas malignas" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0045" "etiqueta" => "Figure 9" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr9.jpeg" "Alto" => 1387 "Ancho" => 1839 "Tamanyo" => 864485 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Histopathologic characteristics of spiradenocarcinoma. A, Panoramic view showing a spiradenoma in the dermis and a spiradenocarcinoma nodule in the subcutaneous tissue. B, The nodule is formed by a sheet of neoplastic cells. C, Note the pleomorphic nuclei and frequent mitotic figures in the neoplastic cells. D. High-magnification view of neoplastic cells, several of which are in mitosis. (Hematoxylin-eosin, original magnification ×10 [A], ×40 [B], ×200 [C], ×400 [D]).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Bernárdez, L. Requena" "autores" => array:2 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Bernárdez" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Requena" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017302077" "doi" => "10.1016/j.ad.2017.04.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302077?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303591?idApp=UINPBA000044" "url" => "/15782190/0000010900000001/v1_201801020547/S1578219017303591/v1_201801020547/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S157821901730358X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.11.002" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1770" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:2-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 309 "formatos" => array:3 [ "EPUB" => 22 "HTML" => 207 "PDF" => 80 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Contact Dermatitis to Topical Antiseptics: The Position of Mercromina Film®" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "2" "paginaFinal" => "3" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dermatitis de contacto a antisépticos tópicos. ¿Qué posición ocupa la Mercromina Film®?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Navarro-Triviño" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Navarro-Triviño" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017304611" "doi" => "10.1016/j.ad.2017.08.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017304611?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730358X?idApp=UINPBA000044" "url" => "/15782190/0000010900000001/v1_201801020547/S157821901730358X/v1_201801020547/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Opinion Article</span>" "titulo" => "Position Statement of the Spanish Academy of Dermatology and Venereology on Teledermatology" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "4" "paginaFinal" => "5" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "D. Moreno-Ramírez, G. Romero-Aguilera, P. Pasquali, S. Vaño, L. Ríos-Buceta, J. Malvehy, R. Taberner, L. Ferrándiz" "autores" => array:9 [ 0 => array:4 [ "nombre" => "D." "apellidos" => "Moreno-Ramírez" "email" => array:2 [ 0 => "david.moreno.ramirez.sspa@juntadeandalucia.es" 1 => "dmoreno@e-derma.org" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "G." "apellidos" => "Romero-Aguilera" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "P." "apellidos" => "Pasquali" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "S." "apellidos" => "Vaño" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "L." "apellidos" => "Ríos-Buceta" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "J." "apellidos" => "Malvehy" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "R." "apellidos" => "Taberner" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "L." "apellidos" => "Ferrándiz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 8 => array:1 [ "colaborador" => "e-Dermatology and Imaging Group of the Spanish Academy of Dermatology and Venereology" ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Unidad de Gestión Clínica de Dermatología, Hospital Universitario Virgen Macarena, Sevilla, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Pius de Valls, Valls, Tarragona, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Junta Directiva, Academia Española de Dermatología y Venereología, Madrid, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Clínic, Barcelona, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Dermatología Hospital Son Llàzter, Palma de Mallorca, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Posicionamiento de la Academia Española de Dermatología y Venereología sobre la teledermatología" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Telemedicine is a reality in healthcare today and is considered to be of strategic importance by the World Health Organization.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">1</span></a> Telemedicine improves the provision of healthcare services in areas with poor access to medical resources and enhances the quality of care in areas with better access. Teledermatology (TD) is one of the most common applications of telemedicine.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">During the past decade, Spain has become a world leader in TD services. Between 2009 and 2014, the number of TD programs in Spain increased significantly.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">TD has been shown to improve patient access to specialized care for specific skin conditions and to dermatologic care in general. At the same time, TD has also encountered obstacles and barriers that may have limited its use on a larger scale.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The Spanish Academy of Dermatology and Venereology (AEDV) supports the rational application of TD to improve the quality of care for skin diseases provided that it meets a series of important criteria. The association specifies that the practice of TD must always comply with the following set of basic standards.<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0025" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD refers to the use of information and communication technologies (ICT) in the care of skin diseases</span>. TD is a complementary tool used in the practice of dermatology and, as such, must be used or coordinated solely by specialist dermatologists with the necessary skills and training in e-health processes and the use of ICT in medical practice.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0030" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Leadership of the dermatologist.</span> The leadership of a dermatologist must be a fundamental prerequisite in the design and implementation of all TD programs. All programs and initiatives using ICT to provide dermatologic care must be led by a dermatologist at every stage. The dermatologist must play a coordinating role in multidisciplinary teams developing or using TD.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0035" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">All TD programs must include the support of a dermatologist who is available for in-person consultations.</span> TD is complementary to the practice of face-to-face dermatology. It can be used to facilitate triage, prioritization, and patient referral and is in no case a substitute for the availability, when necessary, of an in-person consultation with a dermatologist.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4.</span><p id="par0040" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD should be used to respond to an identified need for improvement in a healthcare process.</span> As a complementary tool for delivering dermatologic care, TD should be integrated into the overall care process to respond to the specific needs identified (accessibility, prioritization, coordination between care levels, follow-up of patients with chronic disease, continuous training, etc.). It is essential in the design of TD programs to identify the stages and activities in a particular process that are likely to be improved by the use of the methodology. The practice of TD should always be regulated by clearly defined work procedures and referral protocols.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">5.</span><p id="par0045" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD must be incorporated into the organization's portfolio of services.</span> TD activity must be incorporated into the authorized portfolio of services of both the dermatology service providers and other participants (primary care centers, other hospital departments). All TD activity should be part of a program that is formally recognized and authorized by the relevant hospital, health care center, and/or health authority.</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">6.</span><p id="par0050" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD programs must be allocated specific and adequate resources to ensure good practice.</span> In the programmed schedule of activities of a dermatology department or clinic, time must be specifically allocated for all of the work involved in a TD program (teleconsultations, training, resolving technical problems, etc.). All TD programs must use equipment and software designed for the specific purpose to ensure ease of use for those operating the system and secure data transmission. TD applications must be integrated into the corporate information system.</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">7.</span><p id="par0055" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">TD programs must be supported by comprehensive training programs.</span> All professionals participating in a TD program must complete a training program specific to their role: operators (training in obtaining images, user interfaces, etc.), primary care physicians or other specialist physicians (training in criteria for teleconsultation, referral paths etc.), dermatologists (training in decision making, the user interface, etc.). TD training programs must be updated and maintained as long as the program is in operation.</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">8.</span><p id="par0060" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">The use of TD must be monitored by way of an integrated validation and quality control program.</span> All TD programs must undergo an initial validation process in all the dimensions that will be continuously monitored (efficacy, safety, diagnostic validity, efficiency, and user satisfaction). Monitoring is also essential to identify errors and deviations from the protocol and to facilitate a quality-control system that will ensure ongoing improvement. AEDV will publish guidelines on clinical practice using TD in order to establish standards for the process and to provide clinical guidelines for dermatologists.</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">9.</span><p id="par0065" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">The modality of TD used in each case must be the one that can provide the most efficiency and clinical safety for the specific healthcare need to be met.</span> All the TD methodologies (store-and-forward, real time, mixed, mobile) and modalities of interaction between the participants (primary TD, patient-dermatologist; secondary TD, primary care physician-dermatologist; tertiary, dermatologist-dermatologist) have been shown to have strengths and weaknesses. Physicians should use the method best adapted to the health condition or group of conditions being addressed. Selecting the process in which TD has shown the greatest efficacy is the best guarantee of clinical safety for both patient and dermatologist.</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel"><span class="elsevierStyleItalic">10.</span></span><p id="par0070" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">The TD process must respect the patients’ right to choice and ensure their confidentiality at all times.</span> The practice of TD must always include a procedure that defines the purposes and uses of the images obtained and transmitted. All applications used in TD must fulfil the confidentiality and privacy requirements required under current personal data protection legislation<span class="elsevierStyleItalic">.</span> It is advisable to specify the limitations of TD in a safeguard clause, which should be included in all the reports issued by clinicians.</p></li></ul></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Moreno-Ramírez D, Romero-Aguilera G, Pasquali P, Vaño S, Ríos-Buceta L, Malvehy J, et al. Posicionamiento de la Academia Española de Dermatología y Venereología sobre la teledermatología. Actas Dermosifiliogr. 2018;109:4–5.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Références" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:2 [ 0 => array:3 [ "identificador" => "bib0015" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Telemedicine: Opportunities and developments in Member States: Report on the second global survey on eHealth 2009. Global observatory for eHealth Series, 2. WHO Library Cataloguing in-Publication Data. Geneva, Switzerland; 2011 [cited 26 Abril 2016]. Available from: <a href="http://apps.who.int/iris/bitstream/10665/44497/1/9789241564144_eng.pdf">http://apps.who.int/iris/bitstream/10665/44497/1/9789241564144_eng.pdf</a>" ] ] ] 1 => array:3 [ "identificador" => "bib0020" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Teledermatología, del debate a la calma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D. Moreno-Ramírez" 1 => "G. Romero-Aguilera" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2016.01.006" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr." "fecha" => "2016" "volumen" => "107" "paginaInicial" => "366" "paginaFinal" => "368" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26956401" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack326620" "titulo" => "Acknowledgments" "texto" => "<p id="par0075" class="elsevierStylePara elsevierViewall">This document was drawn up by the e-Dermatology and Imaging Group and the Board of Directors of the Spanish Academy of Dermatology and Venereology.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010900000001/v1_201801020547/S1578219017303815/v1_201801020547/en/main.assets" "Apartado" => array:4 [ "identificador" => "6152" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Opinion Article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010900000001/v1_201801020547/S1578219017303815/v1_201801020547/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303815?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 6 | 11 |
| 2024 October | 83 | 39 | 122 |
| 2024 September | 80 | 20 | 100 |
| 2024 August | 103 | 48 | 151 |
| 2024 July | 65 | 37 | 102 |
| 2024 June | 77 | 44 | 121 |
| 2024 May | 65 | 35 | 100 |
| 2024 April | 71 | 31 | 102 |
| 2024 March | 74 | 31 | 105 |
| 2024 February | 64 | 32 | 96 |
| 2024 January | 55 | 33 | 88 |
| 2023 December | 45 | 20 | 65 |
| 2023 November | 84 | 32 | 116 |
| 2023 October | 76 | 21 | 97 |
| 2023 September | 57 | 27 | 84 |
| 2023 August | 33 | 16 | 49 |
| 2023 July | 67 | 27 | 94 |
| 2023 June | 47 | 20 | 67 |
| 2023 May | 58 | 26 | 84 |
| 2023 April | 48 | 26 | 74 |
| 2023 March | 47 | 29 | 76 |
| 2023 February | 49 | 36 | 85 |
| 2023 January | 48 | 35 | 83 |
| 2022 December | 46 | 42 | 88 |
| 2022 November | 39 | 21 | 60 |
| 2022 October | 25 | 22 | 47 |
| 2022 September | 27 | 41 | 68 |
| 2022 August | 34 | 37 | 71 |
| 2022 July | 26 | 36 | 62 |
| 2022 June | 21 | 19 | 40 |
| 2022 May | 37 | 43 | 80 |
| 2022 April | 47 | 37 | 84 |
| 2022 March | 55 | 61 | 116 |
| 2022 February | 35 | 25 | 60 |
| 2022 January | 46 | 42 | 88 |
| 2021 December | 46 | 44 | 90 |
| 2021 November | 54 | 54 | 108 |
| 2021 October | 66 | 65 | 131 |
| 2021 September | 41 | 53 | 94 |
| 2021 August | 54 | 48 | 102 |
| 2021 July | 35 | 38 | 73 |
| 2021 June | 26 | 45 | 71 |
| 2021 May | 37 | 53 | 90 |
| 2021 April | 71 | 68 | 139 |
| 2021 March | 76 | 45 | 121 |
| 2021 February | 60 | 40 | 100 |
| 2021 January | 48 | 45 | 93 |
| 2020 December | 32 | 30 | 62 |
| 2020 November | 39 | 43 | 82 |
| 2020 October | 28 | 26 | 54 |
| 2020 September | 38 | 25 | 63 |
| 2020 August | 28 | 26 | 54 |
| 2020 July | 33 | 30 | 63 |
| 2020 June | 38 | 52 | 90 |
| 2020 May | 24 | 18 | 42 |
| 2020 April | 24 | 20 | 44 |
| 2020 March | 27 | 19 | 46 |
| 2020 February | 2 | 1 | 3 |
| 2020 January | 4 | 0 | 4 |
| 2019 December | 8 | 0 | 8 |
| 2019 November | 4 | 0 | 4 |
| 2019 September | 8 | 0 | 8 |
| 2019 August | 4 | 0 | 4 |
| 2019 July | 4 | 0 | 4 |
| 2019 June | 6 | 0 | 6 |
| 2019 May | 4 | 0 | 4 |
| 2019 April | 2 | 0 | 2 |
| 2019 March | 4 | 0 | 4 |
| 2019 February | 1 | 0 | 1 |
| 2019 January | 1 | 0 | 1 |
| 2018 December | 10 | 0 | 10 |
| 2018 November | 11 | 0 | 11 |
| 2018 October | 15 | 0 | 15 |
| 2018 September | 5 | 0 | 5 |
| 2018 March | 0 | 1 | 1 |
| 2018 February | 53 | 28 | 81 |
| 2018 January | 76 | 39 | 115 |
| 2017 December | 3 | 7 | 10 |
Show all
